scispace - formally typeset
Open AccessJournal ArticleDOI

Dendritic cell-based immunotherapy

TLDR
What has been learned thus far about human DC biology from clinical studies are discussed, and how current approaches to apply DC vaccines in the clinic could be improved to enhance anti-tumor immunity are discussed.
Abstract
Immunotherapy using dendritic cell (DC)-based vaccination is an approved approach for harnessing the potential of a patient's own immune system to eliminate tumor cells in metastatic hormone-refractory cancer. Overall, although many DC vaccines have been tested in the clinic and proven to be immunogenic, and in some cases associated with clinical outcome, there remains no consensus on how to manufacture DC vaccines. In this review we will discuss what has been learned thus far about human DC biology from clinical studies, and how current approaches to apply DC vaccines in the clinic could be improved to enhance anti-tumor immunity.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Antigen Delivery to DEC205+ Dendritic Cells Induces Immunological Memory and Protective Therapeutic Effects against HPV-Associated Tumors at Different Anatomical Sites.

TL;DR: In this article, the authors employed antibody-antigen conjugates targeting a specific DC C-type lectin receptor, and genetically fused the anti-DEC205 monoclonal antibody to the type 16 human papillomavirus (HPV-16) E7 oncoprotein to create a therapeutic vaccine to treat HPVassociated tumors in syngeneic mouse tumor models.
Journal ArticleDOI

Variegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State

TL;DR: In this article , the diversity of fates and functions of T cells involved in the opposing immunogenic and tolerogenic processes induced in the steady state by the relevant mechanisms of systemic cDC present in murine peripheral lymphoid organs.
Journal ArticleDOI

The DDR-related gene signature with cell cycle checkpoint function predicts prognosis, immune activity, and chemoradiotherapy response in lung adenocarcinoma

TL;DR: In this paper , the authors used the least absolute shrinkage and selection operator (LASSO) regression to construct a prognosis model for lung adenocarcinoma (LUAD) patients.
Journal ArticleDOI

Adoptive cell therapy for acute myeloid leukemia

TL;DR: The clinical application and advancement of donor lymphocyte infusion, chimeric-antigen receptor (CAR) T cell therapy, natural killer (NK) cell therapy and dendritic cell vaccination for AML are reviewed, hopefully providing an overview of clinical aspects of advances in adoptive cell therapy forAML.
References
More filters
Journal ArticleDOI

Toll-like receptor signalling

TL;DR: Rapid progress that has recently improved the understanding of the molecular mechanisms that mediate TLR signalling is reviewed.
Journal ArticleDOI

Immunobiology of Dendritic Cells

TL;DR: Dendritic cells are antigen-presenting cells with a unique ability to induce primary immune responses and may be important for the induction of immunological tolerance, as well as for the regulation of the type of T cell-mediated immune response.
Journal ArticleDOI

Neoantigens in cancer immunotherapy

TL;DR: Observations indicate that neoantigen load may form a biomarker in cancer immunotherapy and provide an incentive for the development of novel therapeutic approaches that selectively enhance T cell reactivity against this class of antigens.
Related Papers (5)